Sol-Gel Technologies Price to Sales Ratio 2016-2024 | SLGL

Historical PS ratio values for Sol-Gel Technologies (SLGL) over the last 10 years. The current P/S ratio for Sol-Gel Technologies as of November 20, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Sol-Gel Technologies P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-11-19 0.43 1.83
2024-06-30 0.89 $0.24 3.77
2024-03-31 0.98 $0.06 15.72
2023-12-31 1.11 $0.06 19.17
2023-09-30 1.63 $0.05 35.81
2023-06-30 2.99 $0.05 60.83
2023-03-31 3.88 $0.18 21.58
2022-12-31 4.56 $0.17 27.16
2022-09-30 5.02 $1.07 4.71
2022-06-30 4.10 $1.43 2.87
2022-03-31 7.38 $1.32 5.61
2021-12-31 7.40 $1.35 5.50
2021-09-30 10.00 $0.53 18.69
2021-06-30 12.38 $0.25 48.76
2021-03-31 12.38 $0.26 47.07
2020-12-31 9.79 $0.39 24.80
2020-09-30 7.24 $0.51 14.21
2020-06-30 8.95 $0.66 13.64
2020-03-31 7.06 $1.02 6.93
2019-12-31 17.15 $1.19 14.39
2019-09-30 8.99 $0.99 9.12
2019-06-30 9.11 $0.75 12.16
2019-03-31 6.77 $0.34 19.91
2018-12-31 6.02 $0.01 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.012B $0.002B
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00